Apnimed, Inc. Common Stock (APMD) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US03770Y1073
Apnimed, Inc. Common Stock financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 8.01 m USD | 38.47 m USD |
| Gross profit | 4.64 m USD | 31.77 m USD |
| Operating income | -114.23 m USD | -53.82 m USD |
| EBIT | -114.23 m USD | -53.82 m USD |
| Net income | -111.31 m USD | -932,000.00 USD |
| Diluted EPS – continuing operations | -2.79 USD | -0.02 USD |
Full history since 2024, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Apnimed, Inc. Common Stock
Apnimed, Inc. operates as a clinical pharmaceutical company that develops and manufactures novel oral therapies that address the neurobiology of sleep-related breathing diseases in global markets. It offers AD109, an oral therapy designed to treat obstructive sleep apnea (OSA) by targeting the underlying neuromuscular dysfunction. The company was incorporated in 2017 and is headquartered in Cambridge, Massachusetts.
More stocks
- Pinewood Technologies Group PLC (PINE.L)
- Jiangyin Pivot Automotive Products Co. Ltd. (301181.SZ)
- Sam Hwa Capaci (001820.KS)
- Chongqing QinAn M&E PLC (603758.SS)
- Lingyuan Iron & Steel Co Ltd (600231.SS)
- Mengtian Home Group Inc. (603216.SS)
- Zignago Vetro SpA (ZV.MI)
- Ooh!Media Ltd (OML.AX)
- Northern Data (NB2.DE)
- Festi hf (FESTI.IC)
- KOPIN CORP (KOPN)
- Interfor Corp (IFP.TO)
Not investment advice. All data without warranty, price as of 06.11.2026. Details in the risk notice.